American Portfolios Advisors Atara Biotherapeutics, Inc. Transaction History
American Portfolios Advisors
- $2.36 Trillion
- Q3 2022
A detailed history of American Portfolios Advisors transactions in Atara Biotherapeutics, Inc. stock. As of the latest transaction made, American Portfolios Advisors holds 4,500 shares of ATRA stock, worth $52,515. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,500Holding current value
$52,515% of portfolio
0.0%Shares
8 transactions
Others Institutions Holding ATRA
# of Institutions
8Shares Held
3.06MCall Options Held
0Put Options Held
0-
Kpcb Xv Associates, LLC1.88MShares$21.9 Million19.79% of portfolio
-
Antipodean Advisors LLC New York, NY1MShares$11.7 Million8.12% of portfolio
-
Boxer Capital, LLC San Diego, CA166KShares$1.94 Million0.08% of portfolio
-
Ifp Advisors, Inc4.5KShares$52,5150.0% of portfolio
-
Wipfli Financial Advisors Llc,3.08KShares$35,9310.0% of portfolio
About Atara Biotherapeutics, Inc.
- Ticker ATRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,362,304
- Market Cap $1.1B
- Description
- Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...